NasdaqGM - Nasdaq Real Time Price USD
Neurogene Inc. (NGNE)
15.37
-0.07
(-0.45%)
At close: April 24 at 4:00:00 PM EDT
14.61
-0.76
(-4.94%)
After hours: April 24 at 6:18:49 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-70,603
-70,603
-51,422
-52,824
-46,400
Investing Cash Flow
-125,261
-125,261
25,637
-2,230
-18,369
Financing Cash Flow
184,071
184,071
92,482
66,531
51,063
End Cash Position
136,925
136,925
148,718
82,021
70,544
Interest Paid Supplemental Data
12
12
12
2
--
Capital Expenditure
-808
-808
-321
-2,230
-18,369
Issuance of Capital Stock
189,589
189,589
92,343
66,459
50,776
Repayment of Debt
-52
-52
-29
-1
--
Free Cash Flow
-71,411
-71,411
-51,743
-55,054
-64,769
12/31/2021 - 3/7/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KRRO Korro Bio, Inc.
17.44
-2.90%
TSHA Taysha Gene Therapies, Inc.
1.8200
0.00%
LXEO Lexeo Therapeutics, Inc.
3.6700
+8.90%
TRML Tourmaline Bio, Inc.
17.32
-2.81%
DYN Dyne Therapeutics, Inc.
11.11
+3.06%
RARE Ultragenyx Pharmaceutical Inc.
37.64
+0.88%
SRRK Scholar Rock Holding Corporation
34.38
+5.72%
RGNX REGENXBIO Inc.
9.20
+3.72%
FBRX Forte Biosciences, Inc.
6.96
+15.04%
FDMT 4D Molecular Therapeutics, Inc.
3.2500
-4.97%